fig1

No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis

Figure 1. PRISMA study flow chart. HCC: hepatocellular carcinoma.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/